• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Life Sciences | News, Analysis, Insights - HIT Consultant

Verily Acquires Clinical Trials Management Platform SignalPath, Marks First Acquisition

by Fred Pennic 08/17/2021 Leave a Comment

Verily Acquires Clinical Trials Management Platform SignalPath, Marks First Acquisition

What You Should Know: Verily, an Alphabet company announced an agreement to acquire SignalPath, a Raleigh, NC-based clinical trial management system (CTMS) that improves the ease, quality and efficiency of conducting clinical research at study sites. Financial details of the acquisition were not disclosed. - The acquisition marks Verily’s first major acquisition that will strengthen and expand Verily’s existing clinical trial system and evidence generation platform, known as Baseline. The
Read More

Reify Health Secures $220M to Go Beyond Decentralized Clinical Trials

by Jasmine Pennic 08/11/2021 Leave a Comment

Reify Health Secures $220M to Go Beyond Decentralized Clinical Trials

What You Should Know: - Reify Health, a Boston-based company paving the way to faster, predictable, and more accessible clinical trials, today announced it has raised $220M in a Series C funding round led by Coatue Management, joined by ICONIQ Growth and Adams Street Partners, as well as existing investors Sierra Ventures and Battery Ventures. This latest funding brings the company’s valuation to $2.2B. - Reify Health has built a new foundation for how clinical trials are run through its
Read More

Colgate Taps Verily’s Baseline Platform for Oral Health Research

by Jasmine Pennic 08/06/2021 Leave a Comment

Colgate Taps Verily’s Baseline Platform for Oral Health Research

What You Should Know: - Verily and Colgate, today announce a new oral health study as part of Verily’s ongoing Baseline Health Study that will aim to improve understanding of the connections between oral health and overall human health. The study will assess how oral health practices affect health more broadly. - The study’s goal is to see how oral health practices, including intensive non-surgical periodontal therapy, as well as a robust Colgate home oral hygiene regimen monitored through
Read More

Cardinal Health Leverages Blockchain to Streamline Pharmaceutical Supply Chain

by Fred Pennic 08/03/2021 Leave a Comment

Cardinal Health Leverages Blockchain to Streamline Pharmaceutical Supply Chain

What You Should Know: -  Cardinal Health and Chronicled announced a partnership to leverage a new blockchain-powered solution on the MediLedger Network to streamline operations across the pharmaceutical supply chain and enable a reliable, frictionless experience for pharmacies across the country. The new blockchain solution will allow Cardinal Health to optimize the complex process of pharmaceutical chargebacks and create greater connectivity for its suppliers and
Read More

ARTIS Ventures Announces 2021 Class of Healthcare and Life Sciences Fellows

by Jasmine Pennic 08/03/2021 Leave a Comment

ARTIS Ventures Announces 2021 Class of Healthcare and Life Sciences Fellows

What You Should Know: - ARTIS Ventures (“AV”), a venture firm focused on pioneering investments in biotech, health, and life sciences, today announced the candidates chosen for the AV Fellows program. The year-long program includes a diverse group of nine fellows from across the world, chosen from more than 150 applicants currently enrolled in a Ph.D. or MD program (or postdoc/residency) with technical expertise ranging from computational biology, synthetic biology, microbiome engineering,
Read More

Syneos Health, Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization

by Jasmine Pennic 08/02/2021 Leave a Comment

Syneos Health, Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization

What You Should Know: - Aetion, a leader in real-world evidence analysis, and Syneos Health® (Nasdaq:SYNH), one of the largest CROs, announced a partnership to provide regulatory-grade data and analytics-driven solutions to advance drug development and improve patient outcomes. - The partnership aims to generate meaningful real-world evidence (RWE) across all phases of the product lifecycle – introducing commercial expertise and insights far earlier in the clinical process – to
Read More

How Logmore’s Condition Monitoring System Is Securing COVID-19 Vaccine Distribution

by HITC Staff 07/29/2021 Leave a Comment

How Logmore's Condition Monitoring System Is Securing COVID-19 Vaccine Distribution

With the COVID-19 vaccination rollout in high gear, innovative data technologies are critical to the success of the most ambitious inoculation effort in human history. There are many challenges involved with trying to vaccinate so many people in such a short amount of time. It hasn’t helped that the leading vaccines require extra cold temperatures in order to remain effective. The “cold chain” is a significant challenge even in the most developed countries in the world. In the US, safe
Read More

NVIDIA Launches UK’s Fastest AI Supercomputer for Healthcare Research

by Fred Pennic 07/07/2021 Leave a Comment

NVIDIA Launches UK’s Fastest AI Supercomputer to Advance Healthcare Research

What You Should Know: - NVIDIA launched the UK’s fastest supercomputer -- Cambridge-1, the world’s first collaborative, industry-wide system dedicated to accelerating healthcare and digital biology research using powerful combination of AI and simulation. - At the virtual inauguration, NVIDIA CEO and founder Jensen Huang discussed what NVIDIA’s $100 million investment will mean for the UK. He said the system will enable research breakthroughs at a scale and speed previously impossible with
Read More

Reinventing the Last Mile: Delivering COVID-19 Vaccines to Our Most Vulnerable Populations

by Jason Z. Rose, CEO of AdhereHealth 06/30/2021 Leave a Comment

Reinventing the Last Mile: Delivering COVID-19 Vaccines to Our Most Vulnerable Populations

Over the past several months, the United States has rapidly accelerated its COVID-19 vaccination rates, with close to half of the population receiving at least one dose by the middle of May. With three highly effective vaccine options and numerous public-private partnerships delivering doses to the public, the country certainly appears to be on the right track to building immunity to the virus. However, a closer look at the data reveals significant concerns.  There are clear and persistent
Read More

4G Clinical Secures $230M for Randomization and Trial Supply Management

by Jasmine Pennic 06/29/2021 Leave a Comment

4G Clinical Secures $230M for Randomization and Trial Supply Management

What You Should Know: - 4G Clinical, a cutting-edge randomization and trial supply management (RTSM) company, today announced it has entered into an agreement to receive a growth equity investment of over $230MM from Goldman Sachs Asset Management ("Goldman Sachs"). - Founded in 2015, 4G Clinical's Prancer RTSMⓇ enables life sciences companies to reach First Patient In (FPI) up to 50% faster than other providers and implement mid-study changes more efficiently. 4G Clinical's clinical
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 64
  • Go to page 65
  • Go to page 66
  • Go to page 67
  • Go to page 68
  • Interim pages omitted …
  • Go to page 85
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |